Chemo in Afternoon Works Better Than in Morning, but Only in

For women with diffuse large B-cell lymphoma undergoing chemotherapy, survival was better with less toxicity when the drugs were administered in the afternoon than in the morning.

Related Keywords

Seoul , Soult Ukpyolsi , South Korea , Daejeon , Taejon Gwangyoksi , Kim Jae Kyoung , Department Of Internal Medicine , Seoul National University Hospital , Institute For Basic Science , Koh Young Il , Internal Medicine , Basic Science , Non Hodgkins Lymphoma , Chemotherapy , Skin Cancer , Alignant Skin Neoplasm , Lung Cancer , Ung Carcinoma , Ancer Lung , Biologic Therapy , Toxicology , B Cell Lymphoma , Antineoplastic Drug , Nti Cancer Agents , Evacizumab , Rlotinib , Efitinib , Matinib , Ituximab , U11248 , Unitinib , Rastuzumab , Cancer , Alignant Neoplasia , Arcinoma , Hospitals , Lymphoma , Malignant Lymphoma , Small Cell Lung Cancer , Circadian ,